disordered growth of both endodermal (respiratory epithelium) and mesodermal (vascular) elements satisfies criteria for the pathological diagnosis of a hamartoma.2 Primitive mesenchyme is fetal tissue. By this definition and according to the hypothesis of Mark,' mesenchymal cystic hamartoma of the lung is hamartomatous and congenital. Only seven cases have been reported to date. The nodules and cysts increase very slowly over a period of many years and, although the disease may be detected in infancy,3 three or four decades usually elapse before it comes to clinical attention.14 Neither the epithelial nor the mesenchymal cells have malignant features, but malignant degeneration has been described. [5] [6] [7] Nodules and cysts represent different stages of the disease.' The nodules arise from mesenchyme proliferation in the interstitium. When the nodules reach 1 cm in diameter bronchiolectasis occurs and small cysts form, lined with normal or metaplastic bronchiolar epithelium. Bleeding from systemic arteries into the cysts causes haemoptysis, and rupture of subpleural cysts causes pneumothorax or haemothorax. New nodules continue to appear when the cysts have already developed. Surgery is needed for diagnosis and for treatment of a pneumothorax or haemothorax. The possible benefit of resecting nodules and cysts to preclude malignant transformation must be weighed against the multicentric nature and benign course in most patients. necrotising glomerulonephritis, other tissues occasionally being involved.' Although Anderson et aF did not identify any cardiac complications in their large series of 256 cases, involvement has been reported in 12-30% of patients with the disease.34 Pericarditis, pancarditis and coronary arteritis may occur.5 Aortic valve involvement has rarely been reported in the literature, but angiography confirmed this to be the underlying cause in this patient.
Yanda et alP described a 77 year old woman who presented initially with a cavitary lung lesion but subsequently progressed with extensive pulmonary, ocular, dermatological, and aortic valvular symptoms requiring replacement. Histological examination showed myxomatous change, degeneration of collagen with an insignificant inflammatory response, a feature consistent with our case. Macroscopically the valve leaflets were thickened but there was no mention of paravalvular involvement.
Although characteristic granulomas were not identified in the aortic tissue, the microscopic changes were consistent with a degenerative tissue collagen vascular disease. The aneurysmal dilatations and the defect in the non-coronary cusp were similar with their macroscopically smooth intimal architecture.
These defects were presumed to be acquired manifestations of the underlying disease process. There was no evidence of an infective cause isolated from either tissue or blood microbiology. This was substantiated by a lack of neutrophil or lymphocytic infiltrate in the specimen.
Although our case required further intervention there was no evidence to suggest that the paravalvular leak was due to extension of the underlying disease process rather than a technical complication of valvular repair.
Review of the literature has not revealed any cases where associated paravalvular lesions were found, and indeed, no reports of acute incompetence secondary to the development of an isolated intraleaflet deficiency. 
